PBM (Psyence Biomedical Ltd. Common Shares) Stock Analysis - SEC Filings

Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded Healthcare sector company. As of May 21, 2026, PBM trades at $3.96 with a market cap of $10.57M and a P/E ratio of 0.00. PBM moved +2.56% today. Year to date, PBM is -19.70%; over the trailing twelve months it is -89.32%. Its 52-week range spans $1.92 to $515.56. Rallies surfaces PBM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find PBM SEC filings?

Rallies organizes PBM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

PBM Key Metrics

Key financial metrics for PBM
MetricValue
Price$3.96
Market Cap$10.57M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$515.56
52-Week Low$1.92
Volume1.80K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PBM News

PBM Analyst Consensus

PBM analyst coverage data. Average price target: $0.00.

Common questions about PBM

Where can I find PBM SEC filings?
Rallies organizes PBM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show PBM 10-K and 10-Q filings?
Rallies organizes PBM SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is PBM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PBM. It does not provide personalized investment advice.
PBM

PBM